Search

Search Constraints

You searched for: Author/Creator Godefroy, Olivier

Search Results

1. [P1–378]: ADDED VALUE OF FLORBETABEN PET IMAGING ON DIAGNOSIS AND MANAGEMENT IN COMPLEX CASES OF PATIENTS WITH MILD DEMENTIA ELIGIBLE FOR CSF ANALYSIS IN THE FRENCH CLINICAL PRACTICE SETTING. (1st July 2017)

2. [P2–551]: THE RELATIONSHIP OF HYPERTENSION, DIABETES AND OTHER VASCULAR RISK FACTORS WITH POSTSTROKE COGNITIVE FUNCTION: THE STROKOG (STROKE AND COGNITION) CONSORTIUM. (1st July 2017)

4. Added value of 18F‐florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study. Issue 3 (26th October 2017)

5. Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic Stroke. Issue 4 (April 2020)

6. Cerebral microbleeds and CSF Alzheimer biomarkers in primary progressive aphasias. (20th March 2018)

8. Cerebrovascular disease in patients with cognitive impairment: A white paper from the ESO dementia committee – A practical point of view with suggestions for the management of cerebrovascular diseases in memory clinics. (June 2021)

9. Clinical relevance of brain atrophy subtypes categorization in memory clinics. Issue 4 (15th December 2020)

10. Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment. (31st October 2021)